Loading in 2 Seconds...
Loading in 2 Seconds...
Various advantages of advanced drug delivery systems over the conventional delivery systems such as on site action, reduce dosing amount, increased drug efficacy, therapeutic success rate etc. support its market growth. In addition, increasing clinical research activities in the development of more advanced drug delivery systems would also be fuelling the market growth. Certain technical limitations in the development of methods, stringent regulations, high pricing for the advanced products, non-availability in the low income countries are some of the factors limiting the market growth of global advanced drug delivery systems.
Advanced Drug Delivery Systems Market
During 2017 – 2025
Advanced drug delivery systems are the improved methods for delivering the drug
molecule to the targeted site in a more controlled manner. These methods are
developed in order to improve the efficacy ratio of the currently available drugs.
Delivering drug at the controlled rate, slow and targeted delivery for onsite drug
release and absorption are the basis for the development of advanced drug delivery
systems. Furthermore, the development of improved methods of drug delivery is
preferred these days over the search for novel molecules. There are various dosage
forms available by which a drug substance can be incorporated for efficacious
delivery. Advancements in biotechnology and nanotechnology have significantly
boosted the development of novel drug delivery approaches. Various
interdisciplinary studies in the field of polymer science, pharmaceuticals, organic
chemistry and molecular biology are required for the development of advanced
drug delivery systems. The drug delivery system comprise of drug formulation,
dosage form and mechanism of release. These advanced delivery systems have the
potential of overcoming one of the major problem faced by the pharmaceutical
industry for the onsite drug efficacy. Development of advanced drug delivery
systems needs into consideration several factors such as pharmacodynamics, drug
toxicity, immunogenicity, bio compatibility, pharmacokinetics as well as drug
Most of the advanced drug delivery systems are developed keeping in mind the
cancer treatment as the chemotherapy drugs needs to have deeper penetration into
the cancer site as well avoiding various associated side effects.
Request for Table of Contents
Various advantages of advanced drug delivery systems over the conventional
delivery systems such as on site action, reduce dosing amount, increased drug
efficacy, therapeutic success rate etc. support its market growth. In addition,
increasing clinical research activities in the development of more advanced drug
delivery systems would also be fuelling the market growth. Certain technical
limitations in the development of methods, stringent regulations, high pricing for
the advanced products, non-availability in the low income countries are some of the
factors limiting the market growth of global advanced drug delivery systems.
Development of novel drug delivery systems is dependent on the number of funding
projects for its research and development. The price of the delivery system depends
on the complexity of disease, drug molecule and the delivery mode preferred.
Market growth is also dependent on the adoption rate of these advanced delivery
systems by healthcare practitioners. Various advanced drug delivery and drug
targeting systems are currently under development which may fuel the market in
future. Emergence of new bioactive materials and gene therapy are also getting
attention for the development of advanced drug delivery systems. The
collaborations and mergers by the industry players also have a significant impact on
the market for advanced drug delivery systems.
Geographically, the market for advanced drug delivery systems can be segmented
into five regions, North America, Latin America, Europe, Asia Pacific and Middle East
& Africa. North America dominates the global advanced drug delivery systems
market owing to the better adoption of improved drug delivery solutions as well as
follow up of advanced treatment approaches in healthcare. This is followed by the
European market owing to better healthcare infrastructure facilities and growing
number of research activities in the healthcare domain over the region. Asia Pacific
region represents significant market opportunities in the advanced drug delivery
systems due to the improvement in healthcare infrastructure as well as increasing
healthcare spending and rising disease prevalence. Latin America followed by MEA
represents the lowest market share as well as growth rate in the advanced drug
delivery solution with the lower adoption rate over the region.
Get Sample Copy of this Report
Some major key players of advanced drug delivery systems market include NeXstar
Pharmaceuticals, Inc., West Pharmaceutical Services, Inc., AstraZeneca, Sequus
Pharmaceuticals Inc., 3M, Novartis International AG and others.
Persistence Market Research (PMR) is a third-platform research firm. Our research
model is a unique collaboration of data analytics and market research methodology
to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a
multi-disciplinary approach. At PMR, we unite various data streams from multi-
dimensional sources. By deploying real-time data collection, big data, and customer
experience analytics, we deliver business intelligence for organizations of all sizes.
Persistence Market Research
7th Floor, New York City,
NY 10007, United States,
Telephone - +1-646-568-7751
USA – Canada Toll Free: 800-961-0353